Top Markets
Coin of the day
Coeptis Therapeutics Holdings, Inc. Coeptis Therapeutics Holdings, Inc.

Coeptis Therapeutics Holdings, Inc.

COEP
Pozycja w akcjach #28025
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates... Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical and technology company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its therapeutic portfolio includes an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. The company’s product pipeline consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; CD38-Diagnostic, an in vitro screening tool to analyze cancer patients if cancer patients might be appropriate candidates for anti-CD38 mAb therapy; and SNAP-CAR, a chimeric antigen receptor (CAR) therapy for treatment for cancer. In addition, the company offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson’s Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.
Cena akcji
$4.81
Ostatnia synchronizacja: 2026-07-27
Kapitalizacja rynkowa
$29.01M
Zmiana (1 dzień)
-8.56%
Zmiana (1 rok)
-64.66%
Kraj
US
Handel Coeptis Therapeutics Holdings, Inc. (COEP)

Kategoria

Historia ceny akcji dla Coeptis Therapeutics Holdings, Inc. (COEP)
Najwyższa cena zamknięcia: $6.93 dnia 2026-07-01

Najniższa cena zamknięcia: $201.89 dnia 2020-12-01
Historia cen akcji firmy Coeptis Therapeutics Holdings, Inc. od 2020 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -14.55%
2025 310.00%
2024 -80.37%
2023 -39.69%
2022 -84.27%
2021 -1.07%
2020 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$122.91 -13.46%
AU
$753.28 5.84%
CH